Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
Titel:
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
Auteur:
Di Liello, Raimondo Arenare, Laura Raspagliesi, Francesco Scambia, Giovanni Pisano, Carmela Colombo, Nicoletta Frezzini, Simona Tognon, Germana Artioli, Grazia Gadducci, Angiolo Lauria, Rossella Ferrero, Annamaria Cinieri, Saverio De Censi, Andrea Breda, Enrico Scollo, Paolo De Giorgi, Ugo Lissoni, Andrea Alberto Katsaros, Dionyssios Lorusso, Domenica Salutari, Vanda Cecere, Sabrina Chiara Lapresa, Mariateresa Nardin, Margherita Bogani, Giorgio Distefano, Mariagrazia Greggi, Stefano Gargiulo, Piera Schettino, Clorinda Gallo, Ciro Daniele, Gennaro Califano, Daniela Perrone, Francesco Pignata, Sandro Piccirillo, Maria Carmela
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 31 () nr. 10 pagina's 1348-1355
Jaar:
2021
Inhoud:
Uitgever:
IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.